HOME >> MEDICINE >> NEWS
Brain activity reflects differences in types of anxiety

All anxiety is not created equal, and a research team at the University of Illinois now has the data to prove it. The team has found compelling evidence that differing patterns of brain activity are associated with each of two types of anxiety: anxious apprehension (verbal rumination, worry) and anxious arousal (intense fear, panic, or both).

Their work appears this month online in Psychophysiology.

"This study looks at two facets of anxiety that often are not distinguished," said U. of I. psychology professor Gregory A. Miller, co-principal investigator on the study with psychology professor Wendy Heller. "We had reason to think there were different brain mechanisms, different parts of the brain active at different times, depending on what type of anxiety one is facing."

According to a recent national survey, anxiety disorders are the most commonly reported psychiatric disorders in the U.S. The Diagnostic and Statistical Manual of Mental Disorders classifies nearly a dozen different anxiety disorders, from acute stress disorder to obsessive-compulsive disorder to panic attack and PTSD. But those who study and treat patients with anxiety disorders do not always differentiate the patients who worry, fret and ruminate from those who experience the panic, rapid heartbeat or bouts of sweating that characterize anxious arousal. These two kinds of anxiety may occur alone or in combination, with potentially important implications for treatment.

To test whether neural activation patterns supported the hypothesis that these two categories of anxiety are distinct, the researchers selected 42 subjects from a pool of 1,099 undergraduate college students, using psychological tests to categorize them as "high anxious apprehension," "high anxious arousal," or neither.

Other psychological assessments standardized the pool of participants by removing those with mood disorders or other complicating factors.

The researcher
'"/>

Contact: Diana Yates
diya@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign
29-May-2007


Page: 1 2 3

Related medicine news :

1. Brain-boosting pill alleviates post-chemotherapy fogginess
2. Brain inflammation may be friend, not foe, for Alzheimers patients
3. Brain research poised to dramatically advance global society
4. Elsevier announces launch of Brain Stimulation
5. Brains scans of symptomatic Gulf War veterans show differences
6. Brain structure changes years before memory loss begins
7. Brain studies reveal the mechanisms of the voluntary control of visual attention
8. Brains can recover from alcoholic damage but patients should stop drinking as soon as possible
9. Brain images show hysteria not an imaginary disorder
10. Brain changes in patients with migraine
11. Brain cell and face perception research wins Eppendorf/Science Prize

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Brain activity reflects differences types anxiety

(Date:8/3/2015)... ... August 03, 2015 , ... ... 2015 MarketingProfs Bright Bulb B2B Awards. , The MarketingProfs Bright Bulb B2B Awards ... brands. BESLER Consulting's campaign for the launch of their Readmissions Analytics product was ...
(Date:8/3/2015)... ... 03, 2015 , ... To date, many pharmaceutical and biotech ... of benefits, allowing them to gain access to capabilities that cannot be found ... resources, get access to innovation and ensure timely introduction of product into the ...
(Date:8/3/2015)... ... August 03, 2015 , ... A recent survey by ... of Hispanics believe people can positively affect their diabetes, few look beyond diet ... making diet changes was important. Far fewer participants mentioned the need for exercise ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... and the largest online retailer of nutritional supplements, has officially opened the ... for 11 awards in the following categories:, ,     Brand ...
(Date:8/3/2015)... Venice Beach, CA (PRWEB) , ... August 03, ... ... supporting individuals suffering from ALS and amputation , AUGUST 3, 2015 – Since ... DIY category in March 2015, Not Impossible – an organization whose mission is ...
Breaking Medicine News(10 mins):Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 2Health News:Global CRO Market Space Reviewed by Aniruddha Sowale in In-demand Research Report Available at MarketPublishers.com 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4
(Date:8/3/2015)... JUPITER, Fla. , Aug. 3, 2015 /PRNewswire/ ... announced initiation of its second clinical development program ... drug candidate, CL-H1T.  CL-H1T contains ... is being developed as a treatment for migraine ... "Many patients with migraine headaches ...
(Date:8/3/2015)... and FLORHAM PARK, N.J. , ... once-daily naldemedine met its primary and secondary endpoints in ... of opioid-induced constipation (OIC) in adult patients with chronic ... mu-opioid receptor antagonist (PAMORA). This is the third Phase ... key secondary endpoints. Study results showed that ...
(Date:8/3/2015)... ZIONA, Israel , August 3, 2015 /PRNewswire/ ... today announced it received the statistical analysis of results from ... administered in the BVX-005 phase II trial which took place ... which did not exist at the time of the study- ... that caused the epidemic in the United States ...
Breaking Medicine Technology:Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 2Independent Results Show that BiondVax's Universal Flu Vaccine Administered in a Trial 3 Years ago Improves Immunogenicity Against Current Flu H3N2 Epidemic 3
Cached News: